Business Wire

BEARINGPOINT

24.5.2023 08:55:27 CEST | Business Wire | Press release

Share
BearingPoint Client Success Story: Hanseatic Bank Brings Innovative Services to Market Faster by Setting up a Modern Data-integration Platform

Banks today need to continuously upgrade their digital products and services to meet customers’ evolving needs, especially regarding digital payments, and stand out in the fiercely competitive financial services sector.

In a recent client story, BearingPoint explains how it supported Hanseatic Bank in assessing its current IT architecture and then defining the requirements for an integration platform aligned with the bank’s business and IT strategies.

Reshaping the IT infrastructure into a flexible and scalable platform

With Hanseatic Bank, BearingPoint identified various use cases for a minimum viable product (MVP), starting from system integration pain points. A series of workshops held with key stakeholders resulted in developing, implementing, and operating an event-driven integration solution for a payment use case in the cloud that can transform, orchestrate, and process data.

Building on an AWS infrastructure, BearingPoint combined Apache Kafka, an open-source distributed event-streaming platform, and Camunda, a process orchestration platform that designs, orchestrates and improves business processes. The new integration platform including necessary governance is now available to several teams for developing and taking further use cases to production one by one as they arise. Consequently, the future operating model has been redesigned and now focuses on a more decentralized and micro-service approach to bring products and services to market faster, in an iterative way.

“Payment transactions are undergoing major changes. This innovative IT move turned thought leadership into reality in this project. A best-practice approach for modern architecture and efficiency in payments,” said Christian Bruck, Partner at BearingPoint.

Enabling agile ways for building digital service offerings faster

Hanseatic Bank is well-positioned for the future with a modern, scalable, and flexible IT architecture. The bank can now react more quickly to the changing market demands and develop new products and services effectively and efficiently.

Hanseatic Bank has already brought to life an improved digital service that helps customers to select and adjust repayment rates for open credit card transactions. By changing the existing process from an semi-automated processes with human interactions into a reusable real-time process leads to a higher customer satisfaction due to direct response via the banking app or online banking instead of a 24h wait. Further services from different teams are already in the pipeline of the new integration platform.

“The combination of different areas of expertise and team collaboration were key to success. From solution design and business processes to governance and development, BearingPoint delivered with us a successful MVP go-live with a hands-on team,” said Nico Koller, IT Project Lead at Hanseatic Bank.

About Hanseatic Bank

Hanseatic Bank has been at home in Hamburg since it was founded in 1969, but from the outset it has operated with customers and partners throughout Germany. Werner Otto had founded the consumer credit institution to enable customers of Otto Versand to finance their purchases. In 2005, the major French bank Société Générale took over 75 percent of the shares, while the Otto Group continues to hold 25 percent. In the meantime, both the customer base and the product range have expanded significantly. The bank’s business areas now also include deposit business, insurance, receivables management and consumer loans. One specialty is its credit cards with innovative services for customers and cooperation partners. Further information: https://www.hanseaticbank.de.

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

For more information, please visit:

Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005700/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release

First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release

Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures

IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release

IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye